Yahoo
HKSE - Delayed Quote HKD

MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)

6.700 -0.005 (-0.07%)
At close: October 30 at 3:45:02 PM GMT+8
Chart Range Bar
Loading chart for 2235.HK
  • Previous Close 6.705
  • Open 6.700
  • Bid 6.650 x --
  • Ask 6.805 x --
  • Day's Range 6.700 - 6.815
  • 52 Week Range 5.700 - 8.280
  • Volume 1,100
  • Avg. Volume 61,117
  • Market Cap (intraday) 2.638B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 29.13
  • EPS (TTM) 0.230
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 10.60

MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software. It also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials business. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.

www.microtechmd.com

702

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2235.HK
15.51%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

2235.HK
2.62%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

2235.HK
56.18%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

2235.HK
78.03%
HANG SENG INDEX (^HSI)
8.21%

Analyst Insights

View More

Analyst Price Targets

8.88
10.60 Average
6.700 Current
12.33 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.98%

  • Return on Assets (ttm)

    2.09%

  • Return on Equity (ttm)

    4.13%

  • Revenue (ttm)

    828.99M

  • Net Income Avi to Common (ttm)

    82.72M

  • Diluted EPS (ttm)

    0.230

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.54B

  • Total Debt/Equity (mrq)

    3.67%

  • Levered Free Cash Flow (ttm)

    -14.38M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: